- Taldefgrobep is a novel myostatin inhibitor with the potential to be an important therapy for neuromuscular disorders and metabolic diseases including obesity. - Taldefgrobep monotherapy...

For the second time in a row, Rohde & Schwarz participates at Mobile World Congress Kigali. The mobile and wireless testing expert continues its commitment to the mobile industry on the African...

Nutraland USA, Inc., a leading supplier of sustainable and natural ingredients, today announced the launch of Somato™, a groundbreaking whole-food derived melatonin sourced exclusively from...

Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing EXTON, Pa., Oct. 16, 2023 /PRNewswire/ -- West...

Wesco International (NYSE: WCC) will hold its 2023 third quarter earnings conference call on Thursday, November 2, at 10:00 a.m. ET. Dial-in details are below. The live audio webcast and...